Copyright & Trademark Law Community | LexisNexis
Featured Content

02/05/2013 01:15:55 PM EST

Mylan Says Unnamed Inventor Invalidates Merck Vytorin Patent

Posted by

Law360: Intellectual Property

Mylan Pharmaceuticals urged a Federal Circuit panel on Tuesday to invalidate Merck Sharp & Dohme Corp. patents covering the cholesterol drug Vytorin, claiming the drugmaker deceived the U.S. Patent and Trademark Office by leaving off a key co-inventor Read More...